Cookie Policy

Manage your cookies preferences by toggling this button

Health

Producing new antimicrobials and enhancing the current drugs polymorphism to fight drug resistance through a new metabolic engineering framework

Cyrille pauthenier

Nationality French

Year of selection 2012

Institution Université d'Evry-Val-d'Essonne

Country France

Risk Health

Ph.D

3 years

120000 €

TAKING DRUG DESIGN INTO CELLS AND OUT AGAIN

Affordable, new antibiotics are needed and Cyrille Pauthenier hopes to engineer yeast cells to produce them for us. To avoid toxicity, the process will take place on the outside of the cell, making collection of the new drugs easy and harmless.

To add or modify information on this page, please contact us at the following address: community.research@axa.com